Europe Bladder Cancer Diagnostics Market is expected to grow at a CAGR of 8.38% from 2024 to 2030
The Europe bladder cancer diagnostics market size is expected to reach USD 1.33 billion by 2030, registering a CAGR of 8.38% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of bladder cancer, advancements in diagnostic technologies such as liquid biopsy and urine-based tests, and rising awareness about early cancer detection contribute significantly to market growth. Additionally, supportive government initiatives and growing healthcare expenditure further propel the demand for advanced diagnostics. The aging population in Europe, coupled with lifestyle factors such as smoking and exposure to carcinogens, also boosts the need for timely and accurate bladder cancer diagnostics. The market is expected to continue expanding with technological innovations. Non-muscle Invasive Bladder Cancer (NMIBC) remains a significant global health issue, with nearly half of the diagnosed cases experiencing recurrences or progre...